# Aizon

> Aizon is a San Francisco-based software company that builds AI solutions exclusively for pharmaceutical and biotech manufacturing. Its GxP-compliant platform ingests structured and unstructured production data to run electronic batch records, real-time process monitoring, predictive analytics and, increasingly, agentic AI that helps quality and operations teams cut deviations, improve yield and speed batch review. Formerly known as Bigfinite and founded in 2014, the company has raised roughly $45 million and counts pharma names such as Grifols and Curia among its users.

- **Founded:** 2014
- **Headquarters:** San Francisco, California, United States
- **Founders:** Toni Manzano (Co-Founder & Chief Science Officer (CSO)), Pep Gubau (Co-Founder & CEO), Pere Merino (Co-Founder)
- **Team size:** ~150 employees
- **Products:** Aizon Unify, Aizon Execute, Aizon Predict, Aizon Agentic Studio, Aizon Consulting Services
- **Notable:** Rebranded from Bigfinite to Aizon, sharpening focus onto AI for pharma manufacturing., Raised roughly $44.78M total across multiple rounds, including a $20M Series C in February 2024., Built a GxP-compliant AI platform used by pharma manufacturers including Grifols and Curia.

## Products & services

- **Aizon Unify** — An AI-powered intelligent lakehouse platform that integrates unlimited structured and unstructured data sources and contextualizes production data around the batch, enabling digital batch review, real-time monitoring and batch comparison analytics.
- **Aizon Execute** — An intelligent/electronic batch record (iBR/eBR) product that converts master batch records into executable recipes and applies AI to batch processing on the shop floor.
- **Aizon Predict** — Predictive machine-learning models focused on yield optimization and deviation reduction in GxP manufacturing.
- **Aizon Agentic Studio** — A no-code, natural-language application and dashboard builder that lets manufacturing teams create self-service insights and apps without writing code.
- **Aizon Consulting Services** — Implementation and strategy support designed to deliver first results within roughly six weeks.

## Achievements

- Rebranded from Bigfinite to Aizon, sharpening focus onto AI for pharma manufacturing.
- Raised roughly $44.78M total across multiple rounds, including a $20M Series C in February 2024.
- Built a GxP-compliant AI platform used by pharma manufacturers including Grifols and Curia.
- Pre-announced an agentic AI upgrade to its core platform in October 2025, with general availability targeted for early Q1 2026.

## Latest updates

- **2025-10** — Pre-announced a major upgrade integrating agentic AI into its core platform, moving from data management to autonomous insight generation and execution; general availability targeted for early Q1 2026.
- **2024-02** — Closed a $20M Series C led by NewVale Capital, with Atlantic Bridge, Crosslink Capital and Uncork Capital participating.
- **2024** — Advanced its eBR (electronic batch record) solution, later branded within Aizon Execute.

## Links

- Website: https://www.aizon.ai
- LinkedIn: https://www.linkedin.com/company/aizon
- Twitter/X: https://twitter.com/bigfinite_inc

---

Profile page: https://yespress.io/aizon
Published by YesPress — https://yespress.io
Last updated: 2026-07-14